Amoy Diagnostics Co., Ltd. (SHE:300685)
23.45
+0.10 (0.43%)
Mar 3, 2025, 2:45 PM CST
Amoy Diagnostics Revenue
Amoy Diagnostics had revenue of 304.95M CNY in the quarter ending September 30, 2024, with 22.53% growth. This brings the company's revenue in the last twelve months to 1.18B, up 24.55% year-over-year. In the year 2023, Amoy Diagnostics had annual revenue of 1.04B with 23.91% growth.
Revenue (ttm)
1.18B
Revenue Growth
+24.55%
P/S Ratio
7.91
Revenue / Employee
1.06M
Employees
1,119
Market Cap
9.24B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.04B | 201.33M | 23.91% |
Jan 1, 2023 | 842.18M | -74.85M | -8.16% |
Jan 1, 2022 | 917.03M | 188.64M | 25.90% |
Dec 31, 2020 | 728.39M | 150.04M | 25.94% |
Dec 31, 2019 | 578.36M | 139.32M | 31.73% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Sichuan Biokin Pharmaceutical | 5.82B |